Clinical trial
Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism
NCT07466381 is registered in ClinicalTrials.gov with dr. Siti Nurlaela, SpN as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism
- Lead sponsor
- dr. Siti Nurlaela, SpN
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- November 1, 2024
- Completion date
- January 31, 2026
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.